newsfilter
← Latest News
PR Newswire·

Aeglea BioTherapeutics Appoints Hunter C. Smith to Board of Directors

AUSTIN, Texas, Nov. 16, 2021 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare metabolic diseases, today announced